CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 200 of 276 entries

View as:

Youth Empowerment Solutions for Peaceful Communities

Phase: N/A Priority: Normal

NCT ID: NCT00164593 Org: User:

Start: 04/30/05 End: 08/31/09 Due: 08/31/10

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

Phase: N/A Priority: Normal

NCT ID: NCT02236078 Org: User:

Start: 11/30/15 End: 09/30/20 Due: 09/30/21

Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections

Phase: N/A Priority: Normal

NCT ID: NCT00252096 Org: User:

Start: 06/30/03 End: 06/30/10 Due: 06/30/11

Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya

Phase: N/A Priority: Normal

NCT ID: NCT01695304 Org: User:

Start: 01/31/13 End: 06/30/14 Due: 06/30/15

Iron Supplementation Among Low-Income Postpartum Women

Phase: N/A Priority: Normal

NCT ID: NCT00207610 Org: User:

Start: 06/30/03 End: 09/30/07 Due: 09/30/08

Immunogenicity nOPV2 With and Without bOPV

Phase: N/A Priority: Normal

NCT ID: NCT04579510 Org: User:

Start: 02/08/21 End: 12/23/21 Due: 12/23/22

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Phase: N/A Priority: Normal

NCT ID: NCT01125696 Org: User:

Start: 05/31/12 End: 08/31/18 Due: 08/31/19

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study

Phase: N/A Priority: Normal

NCT ID: NCT03722004 Org: User:

Start: 12/18/18 End: 12/19/19 Due: 12/19/20

Health Promotion of People With Disabilities

Phase: N/A Priority: Normal

NCT ID: NCT00164489 Org: User:

Start: 10/31/03 End: 06/30/05 Due: 06/30/06

Dosage Effects of Folic Acid on Blood Folates of Honduran Women

Phase: N/A Priority: Normal

NCT ID: NCT00207532 Org: User:

Start: 03/31/05 End: 06/30/05 Due: 06/30/06

Program Evaluation of People With Arthritis Can Exercise

Phase: N/A Priority: Normal

NCT ID: NCT00153309 Org: User:

Start: 06/30/03 End: 06/30/05 Due: 06/30/06

Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012

Phase: N/A Priority: Normal

NCT ID: NCT01730313 Org: User:

Start: 02/29/16 End: 07/31/17 Due: 07/31/18

Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel

Phase: N/A Priority: Normal

NCT ID: NCT04523324 Org: User:

Start: 10/31/19 End: 08/30/22 Due: 08/30/23

Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria

Phase: N/A Priority: Normal

NCT ID: NCT00140361 Org: User:

Start: 01/31/00 End: 01/31/08 Due: 01/31/09

Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines

Phase: N/A Priority: Normal

NCT ID: NCT00229775 Org: User:

Start: 07/31/03 End: 07/31/08 Due: 07/31/09

Just-in-time Elastomeric Training and Fit Testing (JET FIT)

Phase: N/A Priority: Normal

NCT ID: NCT03888898 Org: User:

Start: 04/02/19 End: 02/01/21 Due: 02/01/22

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

Phase: N/A Priority: Normal

NCT ID: NCT00126906 Org: User:

Start: 10/31/02 End: 03/31/05 Due: 03/31/06

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Phase: N/A Priority: Normal

NCT ID: NCT03722589 Org: User:

Start: 09/12/18 End: 07/31/20 Due: 07/31/21

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Phase: N/A Priority: Normal

NCT ID: NCT00023426 Org: User:

Start: 07/31/99 End: 02/28/03 Due: 02/28/04

Pakistan Flocculent Health Outcome Study

Phase: N/A Priority: Normal

NCT ID: NCT01538953 Org: User:

Start: 03/31/03 End: 01/31/04 Due: 01/31/05

Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT00425763 Org: User:

Start: 05/31/07 End: 08/31/07 Due: 08/31/08

Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.

Phase: N/A Priority: Normal

NCT ID: NCT00139087 Org: User:

Start: 01/31/02 End: 03/31/05 Due: 03/31/06

An Arts-Based Initiative for the Prevention of Violence Against Women and Girls

Phase: N/A Priority: Normal

NCT ID: NCT00164541 Org: User:

Start: 09/30/04 End: 09/30/06 Due: 09/30/07

Brief Intervention to Increase Safety Belt Use Among ED Patients

Phase: N/A Priority: Normal

NCT ID: NCT00300859 Org: User:

Start: 02/28/06 End: 10/31/06 Due: 10/31/07

Testing the POWER Project: A Neighborhood Intervention Trial

Phase: N/A Priority: Normal

NCT ID: NCT00164671 Org: User:

Start: 11/30/03 End: 08/31/05 Due: 08/31/06

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Youth Empowerment Solutions for Peaceful Communities	NCT00164593	Centers for Disease Control and Prevention	user2@example.com	None	2005-04-30	2009-08-31	2010-08-31	-	-	2025-07-14
Brief Bactericidal Activity of Anti-Tuberculosis Drugs	NCT02236078	Centers for Disease Control and Prevention	user2@example.com	None	2015-11-30	2020-09-30	2021-09-30	-	-	2025-07-14
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections	NCT00252096	Centers for Disease Control and Prevention	user2@example.com	None	2003-06-30	2010-06-30	2011-06-30	-	-	2025-07-14
Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya	NCT01695304	Centers for Disease Control and Prevention	user2@example.com	None	2013-01-31	2014-06-30	2015-06-30	-	-	2025-07-14
Iron Supplementation Among Low-Income Postpartum Women	NCT00207610	Centers for Disease Control and Prevention	user2@example.com	None	2003-06-30	2007-09-30	2008-09-30	-	-	2025-07-14
Immunogenicity nOPV2 With and Without bOPV	NCT04579510	Centers for Disease Control and Prevention	user2@example.com	None	2021-02-08	2021-12-23	2022-12-23	-	-	2025-07-14
Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV	NCT01125696	Centers for Disease Control and Prevention	user2@example.com	None	2012-05-31	2018-08-31	2019-08-31	-	-	2025-07-14
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study	NCT03722004	Centers for Disease Control and Prevention	user2@example.com	None	2018-12-18	2019-12-19	2020-12-19	-	-	2025-07-14
Health Promotion of People With Disabilities	NCT00164489	Centers for Disease Control and Prevention	user2@example.com	None	2003-10-31	2005-06-30	2006-06-30	-	-	2025-07-14
Dosage Effects of Folic Acid on Blood Folates of Honduran Women	NCT00207532	Centers for Disease Control and Prevention	user2@example.com	None	2005-03-31	2005-06-30	2006-06-30	-	-	2025-07-14
Program Evaluation of People With Arthritis Can Exercise	NCT00153309	Centers for Disease Control and Prevention	user2@example.com	None	2003-06-30	2005-06-30	2006-06-30	-	-	2025-07-14
Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012	NCT01730313	Centers for Disease Control and Prevention	user2@example.com	None	2016-02-29	2017-07-31	2018-07-31	-	-	2025-07-14
Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel	NCT04523324	Centers for Disease Control and Prevention	user2@example.com	None	2019-10-31	2022-08-30	2023-08-30	-	-	2025-07-14
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria	NCT00140361	Centers for Disease Control and Prevention	user2@example.com	None	2000-01-31	2008-01-31	2009-01-31	-	-	2025-07-14
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines	NCT00229775	Centers for Disease Control and Prevention	user2@example.com	None	2003-07-31	2008-07-31	2009-07-31	-	-	2025-07-14
Just-in-time Elastomeric Training and Fit Testing (JET FIT)	NCT03888898	Centers for Disease Control and Prevention	user2@example.com	None	2019-04-02	2021-02-01	2022-02-01	-	-	2025-07-14
Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi	NCT00126906	Centers for Disease Control and Prevention	user2@example.com	None	2002-10-31	2005-03-31	2006-03-31	-	-	2025-07-14
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP	NCT03722589	Centers for Disease Control and Prevention	user2@example.com	None	2018-09-12	2020-07-31	2021-07-31	-	-	2025-07-14
TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis	NCT00023426	Centers for Disease Control and Prevention	user2@example.com	None	1999-07-31	2003-02-28	2004-02-28	-	-	2025-07-14
Pakistan Flocculent Health Outcome Study	NCT01538953	Centers for Disease Control and Prevention	user2@example.com	None	2003-03-31	2004-01-31	2005-01-31	-	-	2025-07-14
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria	NCT00425763	Centers for Disease Control and Prevention	user2@example.com	None	2007-05-31	2007-08-31	2008-08-31	-	-	2025-07-14
Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.	NCT00139087	Centers for Disease Control and Prevention	user2@example.com	None	2002-01-31	2005-03-31	2006-03-31	-	-	2025-07-14
An Arts-Based Initiative for the Prevention of Violence Against Women and Girls	NCT00164541	Centers for Disease Control and Prevention	user2@example.com	None	2004-09-30	2006-09-30	2007-09-30	-	-	2025-07-14
Brief Intervention to Increase Safety Belt Use Among ED Patients	NCT00300859	Centers for Disease Control and Prevention	user2@example.com	None	2006-02-28	2006-10-31	2007-10-31	-	-	2025-07-14
Testing the POWER Project: A Neighborhood Intervention Trial	NCT00164671	Centers for Disease Control and Prevention	user2@example.com	None	2003-11-30	2005-08-31	2006-08-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance